Advertisement
Product › Details
autoflex™ MALDI-TOF mass spectrometer
Photo and link provided and sponsored by Bruker Daltonik GmbH, Bremen, Germany
![]() |
Next higher product group | MALDI-TOF mass spectrometer |
![]() |
Status | 2000-09-01 sales start |
![]() |
Organisation | Bruker Daltonik GmbH |
| Group | Bruker Corporation (Group) | |
Bruker Daltonics, Inc.. (9/1/00). "Press Release: Bruker Daltonics Announces an Integrated Industrial Biology MALDI–TOF System for Unattended Analyses of >30,000 Samples". Barcelona, Spain.
At the International Mass Spectrometry Conference in Barcelona, Spain, Bruker Daltonics this week introduced new AnchorChips 1536, the autoflex MALDI-TOF industrial mass spectrometer, and genotools bioinformatics software for SNP genotyping
Bruker Daltonics Inc. (NASDAQ: BDAL) this week announced autoflex, the first MALDI-TOF mass spectrometry system specifically designed for very high sample throughput in industrial biology. The autoflex provides ultra-fast, totally automated and unattended analysis of tens of thousands of samples with maximum robustness and reliability of all system components.
The autoflex is designed for industrial biology applications like SNP genotyping or proteomics. New genotools bioinformatics software features the SNP Manager for automated SNP genotyping. For proteomics applications, the autoflex can be equipped with a reflector and PSD tandem mass spectrometry option, as well as the powerful BioTools v 2.0 software for the interpretation of protein data.
Scout MTP MALDI targets are now available in patented AnchorChip technology for highest sensitivity and robust ultra-fast automation. The newest AnchorChip 1536 targets can hold up to 1536 samples. Since the autoflex can be integrated with a Twister microtiter plate handler capable of manipulating 20 targets, the autoflex provides capacity for unattended runs of over 30,000 samples.
The autoflex also features sophisticated self-diagnostics and built-in remote service capabilities. Additional industrialized features of the autoflex include barcode reading for plate identification, an ultrafast X-Y table for very accurate AnchorChip positioning, and a laser capable of over 100 million shots.
"Emerging industrial biology applications in genomics and proteomics require new design approaches for integrated life science systems based on mass spectrometry", commented Frank H. Laukien, Ph.D., President and CEO of Bruker Daltonics. "With this week's introduction of novel cutting-edge products, we expect to further strengthen our leadership position in very high throughput, ultra-sensitive MALDI-TOF mass spectrometry."
Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Its substantial investment in research and development allows it to design, manufacture and market a broad array of products intended to meet the rapidly growing needs of a diverse customer base, including pharmaceutical companies, biotechnology companies, agricultural biotechnology companies, molecular diagnostics companies, academic institutions and government agencies. Bruker Daltonics has diverse technology platforms which integrate automated sample preparation and clean-up, advanced front-end AnchorChips MALDI targets and API source technology with cutting-edge proprietary MALDI-TOF, ESI-TOF, ion trap and FTMS mass analyzers, as well as analysis and bioinformatics software. Bruker Daltonics is also a worldwide leader in supplying mass spectrometry-based systems for substance detection and pathogen identification in security and defense applications.
Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a high degree of risk and uncertainty that exist in the Company's operations and business environment. Such statements are predictions only and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could affect actual events or results include risks associated with performance under the Company's agreements with third parties, research and development progress, competitive products and the strength of the Company's patent portfolio. These factors and others are more fully described under "Risk Factors" in the Final Prospectus included in the Company's Registration Statement on Form S-1 (File No. 333-34820) as filed with the Securities and Exchange Commission and declared effective by the SEC on August 3, 2000.
autoflex, genotools, BioTools, Scout MTP, and AnchorChips are trademarks of Bruker Daltonics Inc.
Twister is a trademark of Zymark Corporation.
For more information, please contact:
Tim Alavosus, Ph.D.
Director of Marketing
Bruker Daltonics Inc.
15 Fortune Drive
Billerica, MA 01821 (USA)
T. (978) 663-3660 x1339
F. (978) 667-5993 Tim.Alavosus@daltonics.bruker.com
Record changed: 2011-11-25 |
More documents for MALDI-TOF mass spectrometer
- [1] Bruker Corporation. (3/31/12). "Press Release: Bruker and University Medical Center Groningen (UMCG) Announce a Collaboration within New European Network for Rapid Identification of Anaerobes (ENRIA)". London....
- [2] Bruker Corporation. (3/31/12). "Press Release: Bruker Expands MALDI Biotyper Capabilities with New Protocols and Reference Libraries for Myobacteria and Multicellilar Fungi". London....
- [3] Bruker Corporation. (3/6/12). "Press Release: Bruker High-field NMR and Mass Spectrometry Instrumentation at the National Polytechnic Institute of Mexico City Will Promote Nanoscience Research in Mexico". Mexico City....
- [4] University of Bremen. (1/29/12). Web Site. MALDI Imaging Core Facility. [http://www.uni-bremen.de, 02/14/12]...
- [5] Bruker Corporation. (1/27/12). "Press Release: Bruker and Siscapa Assay Technologies Announce Joint Publication on SISCAPA-MALDI-TOF Mass Spectrometry for Biomarker Validation and Clinical Research". Billerica, MA....
- [6] Bonislawski, Adam. (12/23/11). "News: UCSF Researchers ID Peptides that May Dramatically Boost HIV Infection Rates"....
- [7] Quotient Bioresearch Ltd.. (9/19/11). "Press Release: Quotient Bioresearch Announces First Use of Bruker MALDI Biotyper for Bacterial Identification"....
- [8] Salk Institute. (7/31/11). Web Site. Mass Spectrometry Core Facility (The Vincent J. Coates Foundation Mass Spectromery Center). [http://www.salk.edu, 07/31/11]...
- [9] Bruker Corporation. (6/27/11). "Press Release: Bruker and Francisco Soria Melguizo S.A. Expand Their Exclusive Agreement for Distribution of th MALDI Biotyper to Cover Spain and Portugal". Geneva....
- [10] Bruker Corporation. (6/27/11). "Press Release: Laboratory Viollier Extends the Business Relationship with Bruker Concerning MALDI Biotyper System for Mass Spectrometry-based Microbial Identification". Geneva....
To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com
» top
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg)









![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)